Back to search
FDAFDA · Food and drugs·Recall number Z-1358-2024

Bio-Rad, REF: 12005660, QXDx BCR-ABL %IS Kit

Published April 3, 2024 · Recall initiated: February 15, 2024

Summary

FDA records medical device Class II recall Z-1358-2024, published April 3, 2024 and initiated February 15, 2024. Recalling firm: Bio-Rad Laboratories; Status: Ongoing; Reported quantity: 33 units; Lot: Lot # 64562656 & 64571846/ UDI: 03610521162834. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to incorrect calibrations and controls, their is a potential of incorrect reporting of lower %IS and molecular response values.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bio-Rad Laboratories
Distributor
US Nationwide distribution in the states of PA, SD, TX, FL, MN.
Lot
Lot # 64562656 & 64571846/ UDI: 03610521162834
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bio-Rad, REF: 12005660, QXDx BCR-ABL %IS Kit recalled?

Yes. FDA published recall Z-1358-2024 on April 3, 2024. Reported hazard: Due to incorrect calibrations and controls, their is a potential of incorrect reporting of lower %IS and molecular response values.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail